Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Country
- 🇨🇳China
- Ownership
- Public, Subsidiary
- Established
- 2002-01-25
- Employees
- 1K
- Market Cap
- -
- Website
- https://www.3s-guojian.com
Clinical Trials
50
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (50 trials with phase data)• Click on a phase to view related trials
Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis
- Conditions
- Dermatitis, Atopic
- Interventions
- Drug: Matching placebo
- First Posted Date
- 2025-06-27
- Last Posted Date
- 2025-06-27
- Target Recruit Count
- 180
- Registration Number
- NCT07042126
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
🇨🇳The Fourth Affiliated Hospital Zhejiang University School of Medicine, Jinhua, Zhejiang, China
🇨🇳Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Nanchang, Zhejiang, China
A Study of Two Different Formulations of 611 in Healthy Adult Subjects in China
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: new formulations of 611Drug: existing formulations of 611
- First Posted Date
- 2025-06-27
- Last Posted Date
- 2025-06-27
- Target Recruit Count
- 180
- Registration Number
- NCT07042113
- Locations
- 🇨🇳
The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, zhejiangsheng, China
🇨🇳Shanghai General Hospital, Shanghai, China
Evaluation of 611 in Chinese Adults Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Conditions
- Pulmonary Disease, Chronic Obstructive (COPD)
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-06-26
- Last Posted Date
- 2025-07-03
- Target Recruit Count
- 594
- Registration Number
- NCT07039669
- Locations
- 🇨🇳
China-Japan Friendship Hospital, Beijing, Beijing, China
🇨🇳Shenzhen People's Hospital, Shenzhen, Guangdong, China
🇨🇳Jiangsu Province Hospital, Nanjing, Jiangsu, China
A Phase IIb Study of 610 in Participants With Severe Eosinophilic Asthma
- First Posted Date
- 2024-11-08
- Last Posted Date
- 2024-11-08
- Target Recruit Count
- 225
- Registration Number
- NCT06680947
Evaluation of 626 in Healthy Adult Subjects
- First Posted Date
- 2024-11-05
- Last Posted Date
- 2024-12-10
- Target Recruit Count
- 50
- Registration Number
- NCT06674525
- Locations
- 🇨🇳
Shanghai General Hospital, Shanghai, China
- Prev
- 1
- 2
- 3
- 4
- 5
- 10
- Next